Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Targeting tumors with salmonella Typhimurium- potential for therapy.

Wall DM, Srikanth CV, McCormick BA.

Oncotarget. 2010 Dec;1(8):721-8. Review.

2.

Tumor-targeting amino acid auxotrophic Salmonella typhimurium.

Hoffman RM.

Amino Acids. 2009 Sep;37(3):509-21. doi: 10.1007/s00726-009-0261-8. Epub 2009 Mar 17. Review.

PMID:
19291366
3.

Bacteria and bacterial toxins as therapeutic agents for solid tumors.

Michl P, Gress TM.

Curr Cancer Drug Targets. 2004 Dec;4(8):689-702. Review.

PMID:
15578923
4.

Phenotypic evolution of therapeutic Salmonella enterica serovar Typhimurium after invasion of TRAMP mouse prostate tumor.

Choe E, Kazmierczak RA, Eisenstark A.

MBio. 2014 Jul 1;5(4):e01182-14. doi: 10.1128/mBio.01182-14.

5.

Direct attachment of nanoparticle cargo to Salmonella typhimurium membranes designed for combination bacteriotherapy against tumors.

Kazmierczak R, Choe E, Sinclair J, Eisenstark A.

Methods Mol Biol. 2015;1225:151-63. doi: 10.1007/978-1-4939-1625-2_11.

PMID:
25253255
7.

Spatial segregation of virulence gene expression during acute enteric infection with Salmonella enterica serovar Typhimurium.

Laughlin RC, Knodler LA, Barhoumi R, Payne HR, Wu J, Gomez G, Pugh R, Lawhon SD, Bäumler AJ, Steele-Mortimer O, Adams LG.

MBio. 2014 Feb 4;5(1):e00946-13. doi: 10.1128/mBio.00946-13.

8.

The preclinical discovery of bacterial therapy for the treatment of metastatic cancer with unique advantages.

Hoffman RM.

Expert Opin Drug Discov. 2012 Jan;7(1):73-83. doi: 10.1517/17460441.2012.644534. Epub 2011 Dec 22. Review.

PMID:
22468895
9.

Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice.

Zhao M, Yang M, Ma H, Li X, Tan X, Li S, Yang Z, Hoffman RM.

Cancer Res. 2006 Aug 1;66(15):7647-52.

10.

Efficiency of conditionally attenuated Salmonella enterica serovar Typhimurium in bacterium-mediated tumor therapy.

Frahm M, Felgner S, Kocijancic D, Rohde M, Hensel M, Curtiss R 3rd, Erhardt M, Weiss S.

MBio. 2015 Apr 14;6(2). pii: e00254-15. doi: 10.1128/mBio.00254-15.

11.

Minicells overcome tumor drug-resistance.

Karagiannis ED, Anderson DG.

Nat Biotechnol. 2009 Jul;27(7):620-1. doi: 10.1038/nbt0709-620. No abstract available.

PMID:
19587665
12.

Development of Salmonella strains as cancer therapy agents and testing in tumor cell lines.

Eisenstark A, Kazmierczak RA, Dino A, Khreis R, Newman D, Schatten H.

Methods Mol Biol. 2007;394:323-54. doi: 10.1007/978-1-59745-512-1_16.

PMID:
18363243
13.

Innate immune response to Salmonella typhimurium, a model enteric pathogen.

Broz P, Ohlson MB, Monack DM.

Gut Microbes. 2012 Mar-Apr;3(2):62-70. doi: 10.4161/gmic.19141. Epub 2012 Mar 1. Review.

14.

Molecular characterization of Irish Salmonella enterica serotype typhimurium: detection of class I integrons and assessment of genetic relationships by DNA amplification fingerprinting.

Daly M, Buckley J, Power E, O'Hare C, Cormican M, Cryan B, Wall PG, Fanning S.

Appl Environ Microbiol. 2000 Feb;66(2):614-9. Erratum in: Appl Environ Microbiol 2000 Apr;66(4):1767.

15.

Salmonella promoters preferentially activated inside tumors.

Arrach N, Zhao M, Porwollik S, Hoffman RM, McClelland M.

Cancer Res. 2008 Jun 15;68(12):4827-32. doi: 10.1158/0008-5472.CAN-08-0552.

16.

Salmonella-allies in the fight against cancer.

Leschner S, Weiss S.

J Mol Med (Berl). 2010 Aug;88(8):763-73. doi: 10.1007/s00109-010-0636-z. Epub 2010 Jun 5. Review.

PMID:
20526574
17.
18.

Salmonella as an innovative therapeutic antitumor agent.

Chang WW, Lee CH.

Int J Mol Sci. 2014 Aug 21;15(8):14546-54. doi: 10.3390/ijms150814546. Review.

19.

Analysis of the Salmonella typhimurium proteome through environmental response toward infectious conditions.

Adkins JN, Mottaz HM, Norbeck AD, Gustin JK, Rue J, Clauss TR, Purvine SO, Rodland KD, Heffron F, Smith RD.

Mol Cell Proteomics. 2006 Aug;5(8):1450-61. Epub 2006 May 8.

20.

Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer.

Zhao M, Geller J, Ma H, Yang M, Penman S, Hoffman RM.

Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10170-4. Epub 2007 Jun 4.

Items per page

Supplemental Content

Write to the Help Desk